These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 21934533

  • 1. Observational study of treatment compliance in women initiating antiresorptive therapy with or without calcium and vitamin D supplements in Spain.
    Díez A, Carbonell C, Calaf J, Caloto MT, Nocea G.
    Menopause; 2012 Jan; 19(1):89-95. PubMed ID: 21934533
    [Abstract] [Full Text] [Related]

  • 2. [Analysis of therapeutic compliance in women with osteoporosis].
    Carbonell Abella C, Guañabens Gay N, Regadera Anechina L, Marín Rives JA, Taverna Llauradó E, Ayechu Redín MP, ADHEPOR.
    Reumatol Clin; 2011 Jan; 7(5):299-304. PubMed ID: 21925445
    [Abstract] [Full Text] [Related]

  • 3. Self-reported compliance with osteoporosis medication-qualitative aspects and correlates.
    Vytrisalova M, Blazkova S, Palicka V, Vlcek J, Cejkova M, Hala T, Pavelka K, Koblihova H.
    Maturitas; 2008 Jan; 60(3-4):223-9. PubMed ID: 18774663
    [Abstract] [Full Text] [Related]

  • 4. Calcium and vitamin D intake by postmenopausal women with osteoporosis in France.
    Czernichow S, Fan T, Nocea G, Sen SS.
    Curr Med Res Opin; 2010 Jul; 26(7):1667-74. PubMed ID: 20446889
    [Abstract] [Full Text] [Related]

  • 5. [Initial treatment trends in patient with osteoporosis: use of antiresorptive agents and pharmacologic supplements (calcium and vitamin D) in clinical practice].
    Carbonell C, Díez A, Calaf J, Caloto MT, Nocea G, Lara N.
    Reumatol Clin; 2012 Jul; 8(1):3-9. PubMed ID: 22118802
    [Abstract] [Full Text] [Related]

  • 6. [Raloxifene in clinical practice. Results of the non-interventional study CORAL (COmpliance with RALoxifene)].
    Rosa J, Vanuga P, Payer J, Svobodník A.
    Vnitr Lek; 2008 Mar; 54(3):217-9, 221-4. PubMed ID: 18522288
    [Abstract] [Full Text] [Related]

  • 7. Ability to follow drug treatment with calcium and vitamin D in postmenopausal women with reduced bone mass.
    de Castro Gomes DA, Valadares AL, Pinto-Neto AM, Morais SS, Costa-Paiva L.
    Menopause; 2012 Sep; 19(9):989-94. PubMed ID: 22668820
    [Abstract] [Full Text] [Related]

  • 8. Total calcium intake is associated with cortical bone mineral density in a cohort of postmenopausal women not taking estrogen.
    Suzuki Y, Whiting SJ, Davison KS, Chilibeck PD.
    J Nutr Health Aging; 2003 Sep; 7(5):296-9. PubMed ID: 12917743
    [Abstract] [Full Text] [Related]

  • 9. Physician and patient perceptions on the use of vitamin D and calcium in osteoporosis treatment: a European and Latin American perspective.
    Resch H, Walliser J, Phillips S, Wehren LE, Sen SS.
    Curr Med Res Opin; 2007 Jun; 23(6):1227-37. PubMed ID: 17559732
    [Abstract] [Full Text] [Related]

  • 10. Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.
    Adachi JD, Hanley DA, Lorraine JK, Yu M.
    Clin Ther; 2007 Sep; 29(9):2055-67. PubMed ID: 18035204
    [Abstract] [Full Text] [Related]

  • 11. [Factors associated with calcium, vitamin D supplements intake and use of hormonal replacement therapy in health workers postmenopausal women].
    Zonana-Nacach A, Armenta-Rivera OT.
    Gac Med Mex; 2007 Sep; 143(4):291-6. PubMed ID: 17969836
    [Abstract] [Full Text] [Related]

  • 12. Compliance with osteoporosis treatment guidelines in postmenopausal women.
    Mountjoy CR, Shrader SP, Ragucci KR.
    Ann Pharmacother; 2009 Feb; 43(2):242-50. PubMed ID: 19196838
    [Abstract] [Full Text] [Related]

  • 13. Management of osteoporosis in postmenopausal women: 2010 position statement of The North American Menopause Society.
    Menopause; 2010 Feb; 17(1):25-54; quiz 55-6. PubMed ID: 20061894
    [Abstract] [Full Text] [Related]

  • 14. Update of current therapeutic options for the treatment of postmenopausal osteoporosis.
    Epstein S.
    Clin Ther; 2006 Feb; 28(2):151-73. PubMed ID: 16678639
    [Abstract] [Full Text] [Related]

  • 15. Incidence and causes for failure of treatment of women with proven osteoporosis.
    Zafran N, Liss Z, Peled R, Sherf M, Reuveni H.
    Osteoporos Int; 2005 Nov; 16(11):1375-83. PubMed ID: 15806322
    [Abstract] [Full Text] [Related]

  • 16. Prescriptions for vitamin D among patients taking antiresorptive agents in Canada.
    Hanley DA, Zhang Q, Meilleur MC, Mavros P, Sen SS.
    Curr Med Res Opin; 2007 Jun; 23(6):1473-80. PubMed ID: 17559742
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Use of calcium supplements, vitamin D supplements and specific osteoporosis drugs among French women aged 75-85 years: patterns of use and associated factors.
    Castro-Lionard K, Dargent-Molina P, Fermanian C, Gonthier R, Cassou B.
    Drugs Aging; 2013 Dec; 30(12):1029-38. PubMed ID: 24114665
    [Abstract] [Full Text] [Related]

  • 19. Treatment persistence and compliance with a combination of calcium and vitamin D.
    Castelo-Branco C, Cortés X, Ferrer M, UNICAD study investigators.
    Climacteric; 2010 Dec; 13(6):578-84. PubMed ID: 19951084
    [Abstract] [Full Text] [Related]

  • 20. Calcium and vitamin D in the prevention and treatment of osteoporosis - a clinical update.
    Boonen S, Vanderschueren D, Haentjens P, Lips P.
    J Intern Med; 2006 Jun; 259(6):539-52. PubMed ID: 16704554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.